CD4 and hepatocellular carcinoma: Our ε‐SVR‐based method, HCCImm, was designed to use the bulk GEPs of HCC samples to predict the abundance of different major immune cell types such as B cells, CD8+ T cells, CD4+ T cells, and macrophages.